Financial Data and Key Metrics Changes - Total revenue for 2025 increased by 13.5% year-over-year, reaching $597 million, while adjusted net income rose by 69% year-over-year to $140 million [3][12][14] - In Q4 2025, revenues were $159 million, a 17% increase compared to Q4 2024, with adjusted net income reaching a record $26 million, up 27% from the previous year [8][10] - GAAP net income for the full year increased by 175% to $146 million, driven by higher revenues and lower expenses [11][13] Business Line Data and Key Metrics Changes - Originations for 2025 totaled $899 million, a 12% increase compared to 2024, contributing to a 16% increase in ending receivables to $493 million [12][14] - In Q4, originations increased by 8% to $230 million compared to the prior year quarter, with ending receivables growing by 16% [8][10] Market Data and Key Metrics Changes - The auto-approval rate in Q4 was 79%, facilitating more customer approvals without human interaction [3] - The company maintained a stable revenue yield of 130% in Q4, reflecting effective risk management [8] Company Strategy and Development Direction - The company plans to release Model 6.1 in the first half of 2026, which is expected to enhance originations and reduce risk through better risk segmentation [4] - The development of Lola, a new origination and servicing system, is underway, with a planned migration in Q3 2026, aimed at leveraging AI tools for improved efficiency [5][6] - A new line of credit product is expected to launch in summer 2026, designed to provide fair and transparent credit access [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit revenue and earnings growth in 2026, supported by improving vintage metrics and strong recovery indicators [4][19] - The impact of inflation and rising gas prices on customer repayment ability is being closely monitored, with management prepared to adjust strategies as needed [25][52] Other Important Information - The company ended Q4 with $93 million in cash equivalents and restricted cash, alongside $321 million in total debt [11] - Total funding capacity stood at $618 million, including $204 million in unused debt capacity [12] Q&A Session Summary Question: Impact of geopolitical events on loss emergence - Management indicated that early indicators of repayment issues can be observed within 28 to 42 days of loan origination, with a focus on monitoring consumer sentiment [17][18] Question: Adjustments in response to rising gas prices - Management acknowledged that inflation affects discretionary income and repayment ability, and they are prepared to target lower-risk customers and adjust pricing if necessary [25][51] Question: Learnings from higher losses in summer vintages - Management noted that no specific type of loan or risk tier stood out as a cause for higher losses, but consumer sentiment is being monitored as an early indicator [36][38] Question: Changes in model development processes - Management confirmed that the advent of AI tools has significantly reduced the cycle times for developing new models, allowing for faster and more predictive model rollouts [54][56]

Financial Data and Key Metrics Changes - Fourth quarter total revenue was approximately $90 million, with Adjusted EBITDA of approximately $7 million, reflecting a temporary margin compression due to lower-margin construction services tied to the WHS segment [11][12] - Total capital spending for the quarter was approximately $16 million, focused on growth in the WHS segment [17] - The company ended the quarter with zero net debt and total available liquidity of approximately $183 million, indicating strong financial flexibility [18] Business Line Data and Key Metrics Changes - The WHS segment generated approximately $40 million in revenue during the fourth quarter, primarily from construction services related to the Workforce Hub contract [12] - The HFS-South and All Other segments generated approximately $36 million in quarterly revenue, with stable cash flows supporting growth initiatives [11] - The WHS segment has secured over $495 million in multiyear awards since February 2025, driving the reactivation of nearly 3,000 beds [7][9] Market Data and Key Metrics Changes - The company is experiencing unprecedented demand across AI infrastructure, critical minerals, and power generation projects, with a robust pipeline of more than 20,000 beds [5][9] - The reactivation of existing assets has reduced available inventory to approximately 3,000-4,000 beds, highlighting the strong demand dynamics in the market [9] Company Strategy and Development Direction - The company aims to advance strategic growth priorities by diversifying its contract portfolio and transitioning into high-growth end markets [4] - Target Hyper/Scale was launched to deliver customized solutions through a vertically integrated accommodations platform, positioning the company to meet rising demand [5] - The WHS segment is expected to become the largest operating segment by the end of 2026, contributing more than 40% of consolidated revenue [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong execution and unprecedented pipeline of opportunities, driven by significant growth in the WHS segment [21] - The company anticipates total revenue of between $320 million and $330 million for 2026, with Adjusted EBITDA of between $60 million and $70 million [18] - Management highlighted the critical role of workforce housing in supporting infrastructure projects, which is expected to enhance pricing power and contract durations [88] Other Important Information - The company has a strong balance sheet and capital flexibility, allowing it to execute on growth initiatives without requiring incremental financing [93] - The Workforce Hub contract value increased by 25% to approximately $170 million due to scope expansion [12] Q&A Session Summary Question: Can you elaborate on the pipeline and the potential to reactivate remaining West Texas assets? - Management indicated that the pipeline continues to grow, with a strong actionable pipeline of over 20,000 beds, and they expect to keep securing wins throughout 2026 [28] Question: Can you provide more details on the potential for variable revenue contribution? - Management explained that the new contracts include a fixed minimum revenue component with potential for variable upside based on customer demand [30] Question: How should we think about the cadence of revenue throughout the year? - Management stated that Q1 will be the low point, with revenue expected to ramp up significantly in Q2 and Q3 as new contracts come online [32] Question: Is there urgency from customers regarding available capacity? - Management confirmed that there is a real concern among customers about capacity, which is working in the company's favor for pricing [51] Question: What are the plans for acquiring additional capacity beyond the current inventory? - Management mentioned that any additional beds required would be built into the contract economics, and they have established relationships with suppliers to secure more beds as needed [61][63] Question: Are you interested in pursuing government-related opportunities? - Management indicated a focus on growing the WHS segment, which they believe offers the greatest value creation opportunities [66] Question: How much of the 20,000 beds pipeline is achievable in the next couple of years? - Management stated that the cadence for the 20,000 beds is actionable within the next 12-24 months, with many projects in advanced stages [85]

Financial Data and Key Metrics Changes - Total revenue for Q4 FY26 grew 9% year-over-year to $220.6 million, with subscription revenue increasing 6% to $193.4 million [5][14] - Non-GAAP operating income was $37.7 million, representing a 17% non-GAAP operating margin [5][17] - For the full year FY26, total revenue was $857.2 million, up 8% year-over-year, with subscription revenue of $756.3 million, up 5% [21][22] - Non-GAAP operating income for the full year was $146.2 million, equating to a non-GAAP net income per diluted share of $0.49 [21][22] Business Line Data and Key Metrics Changes - Professional services revenue for Q4 was $27.1 million, up 29% year-over-year, driven by large-scale rollouts [14][21] - The subscription revenue base net dollar expansion rate in Q4 was 103%, with a net dollar expansion for the $1 million customer cohort at 115% [15][16] - The average revenue per customer in the $1 million cohort is now above $3 million [15] Market Data and Key Metrics Changes - ARR from generative AI-native Sprinklr Service SKUs grew 50% year-over-year, indicating strong demand for AI capabilities [8][10] - The company operates in 12 regions, with the Americas contributing approximately 50-55% of revenue, Europe around 35%, and Asia-Pacific about 10% [40] Company Strategy and Development Direction - The company is in the second phase of its transformation, focusing on embedding changes to build a stronger foundation for scale and efficiency [7][13] - Key innovation priorities include unified customer intelligence, enterprise-wide automation, AI-driven marketing, and next-generation AI insights [9][10] - The company aims to solidify its baseline and contribution from top-tier enterprise customers through a focus on renewal rates and multiyear deals [16] Management's Comments on Operating Environment and Future Outlook - Management noted that while churn was higher than preferred, improvements in renewal rates were observed in Q4, with expectations for continued improvement in Q1 and Q2 [5][13] - The macro environment remains fluid, particularly due to geopolitical events, but the company is focused on maintaining operational discipline [13][14] - Management expressed confidence in the strategy and commitment to delivering durable growth and long-term shareholder value [14][29] Other Important Information - The board has authorized a new $200 million share buyback program, reflecting confidence in the company's strategy and balance sheet [18] - The company generated $15.9 million in free cash flow in Q4 and $142 million for the year, indicating strong cash conversion [17][22] Q&A Session Summary Question: Is the margin outlook conservative? - Management emphasized a balanced approach to investments while ensuring long-term growth and addressing technical debt [31][32] Question: What is the revenue breakdown between international and U.S. markets? - Management indicated that the Middle East is a healthy region with a good pipeline, contributing to overall revenue [39][40] Question: Will elevated churn continue in FY27? - Management expects renewal rates to improve, indicating a positive trend in customer retention [45][46] Question: What are the plans for increasing margins? - Management highlighted a focus on revenue mix and operational efficiency, with investments in AI solutions and disciplined expense management [48][50] Question: What signals the transition to the acceleration phase? - Management noted the importance of improving renewal rates, customer sentiment, and operational efficiency as indicators for moving to the next phase [89]

Financial Data and Key Metrics Changes - Adjusted EBITDA for the full year reached approximately $18.6 million, up 83% from $10.2 million last year, exceeding guidance [4][12][29] - Consolidated total revenue increased by 66% in 2025 to $245.7 million, up from just over $148 million last year [13] - Net income for the year was $15.1 million, up 153% from $6 million in 2024, with diluted EPS improving 133% from $0.24 to $0.56 per share [28][29] Business Line Data and Key Metrics Changes - Revenue from procurement services totaled $197.5 million, up 68% from $117.5 million in 2024, with gross profit margins expanding from 6.7% to 7.7% [13][22] - Revenue from the systems integration segment increased 78% year-over-year to $40.3 million, with Q4 revenues rising from $7.9 million to $14.2 million [16][21] - Facilities management revenue totaled $7.9 million, down 1% from $8 million last year, but discrete project revenues in Q4 increased 263% to $2.5 million [15][21] Market Data and Key Metrics Changes - Customer adoption of AI is broadening, with 70%-80% of medium and large enterprises actively piloting or planning to implement AI in production workflows [7] - The market environment for AI demand is dynamic, with hyperscalers and large enterprises continuing to invest in accelerated computing and associated infrastructure [5][6] Company Strategy and Development Direction - The company aims to seize market share in AI rack integration and expand modular data center capabilities [9][33] - Strategic planning includes evaluating partnerships, acquisitions, and joint ventures to enhance capabilities and diversify revenue [33] - The company is focused on operational excellence and improving speed, quality, and time to value as key differentiators [34] Management's Comments on Operating Environment and Future Outlook - Management is optimistic about the business outlook for 2026, forecasting continued growth in earnings with adjusted EBIT expected in the $20-$22 million range [32] - The company acknowledges supply chain volatility and the timing of deal closings as factors in their conservative estimates [32] - Management emphasizes the importance of trusted partnerships as enterprises modernize and adopt AI technologies [34] Other Important Information - The company ended 2025 with $85.5 million of unrestricted cash, a $62.3 million increase from year-end 2024 [29] - Cash flow from operations increased significantly from $15.3 million in 2024 to over $30 million in 2025 [30] Q&A Session Summary Question: Can you give any more color on the amended agreement with your largest customer? - The agreement includes a term extension and adjustments for infrastructure investments, but minimum order volumes remain unchanged [38][41] Question: How should we be thinking about the amount of catch-up volume you saw this quarter? - Q4 rack volume almost exceeded Q1 through Q3, with expectations to double the business in 2026 [45] Question: What are you seeing in the U.S. federal business with the government shutdown resolved? - The procurement business is strong, with optimism about upcoming opportunities despite previous disruptions [49] Question: Can you talk about the memory chip shortage and its impact? - The company is somewhat insulated from the memory chip shortage due to strong supply chain management by their key partner [56] Question: How do your economics change as server racks get bigger? - The company is prepared for increased complexity and anticipates discussions on potential renegotiations as rack sizes grow [58]

Financial Data and Key Metrics Changes - The company reported a 27% increase in revenue to $14.5 million for Q4 2025, with full-year revenue also growing 27% to $52.2 million compared to 2024 [4][18] - Gross profit for Q4 was $11.1 million, up from $8.5 million in the prior year, increasing gross margin to 76% [19] - Net income for Q4 was $2.9 million, compared to $1.5 million in the same period of 2024, with full-year net income of approximately $7.6 million compared to $2.9 million in 2024 [23] Business Line Data and Key Metrics Changes - The company shipped 95 Deep TMS systems during Q4, bringing the total installed base to approximately 1,700 systems, a 26% increase year-over-year [4][18] - The book-to-bill ratio improved to 1.4x from 1.2x in the previous quarter, indicating strong demand [5] - Remaining performance obligations reached $70 million, representing a 43% growth from $49 million a year ago [5][24] Market Data and Key Metrics Changes - The company has penetrated less than 10% of the market for Deep TMS, indicating significant growth potential [7] - The FDA granted label expansion for Deep TMS to treat adolescents aged 15 to 21 with major depressive disorder, expanding the addressable patient population [9][10] Company Strategy and Development Direction - The company is focusing on expanding reimbursement coverage with payers across the U.S. to support broader adoption of Deep TMS [8] - A strategic initiative is in place to secure minority equity investments in high-performing mental health providers, which is expected to facilitate faster access to interventional psychiatry modalities [14][15] - The long-term vision includes developing a portfolio of data-driven technology-enabled neuromodulation solutions to serve more patients [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the momentum in the business and expects revenue in the range of $66 million to $68 million for 2026, representing a year-over-year growth rate of 27%-30% [24] - The company anticipates adjusted EBITDA of $12 million to $14 million for 2026, indicating expected growth of 86%-100% over 2025 [25] Other Important Information - The company received a $2.5 million NIH grant for a study on Deep TMS for alcohol use disorder, highlighting ongoing clinical research efforts [12][13] - The SWIFT Deep TMS protocol was validated through peer-reviewed studies, which could significantly improve patient access and treatment efficiency [11] Q&A Session Summary Question: Can you give us a better sense of the fourth quarter placements as far as units sold, units leased, and also any color regarding OCD placements? - The company shipped 95 systems during Q4, with more than 50% including the H7 coils [26] Question: Can you talk about the Deep TMS 360 trial that's going on? - The TMS 360 trial is actively recruiting patients for alcohol use disorder in 10 centers across the U.S., aiming to recruit over 200 patients [28][29] Question: Was there any pricing change in 2025 or anticipated for 2026? - The company does not anticipate a decrease in average selling price and aims to optimize pricing based on the value provided [31] Question: What percentage of the $70 million obligations relates to commitments from existing strategic partners? - The minority investment program is expected to deliver new backlog or bookings of between $3-$5 million on a yearly basis from each center [35][36] Question: Do you anticipate significant utilization of the SWIFT protocol in conjunction with other therapies? - There is strong demand for TMS, particularly with the SWIFT protocol, which is being used alongside other modalities like psychedelics and medication management [41]

Financial Data and Key Metrics Changes - Total revenues for 2025 were $180.5 million, representing a 12% year-over-year increase from $161 million in 2024 [5][17] - Adjusted EBITDA was $42 million, up 23% year-over-year from $34.1 million in 2024 [5][19] - Net income for 2025 was $20.2 million or $0.35 per diluted share, a 40% increase compared to $14.5 million or $0.25 per diluted share in 2024 [19] - Cash and cash equivalents at year-end 2025 were $75.5 million, down from $78.4 million in December 2024 [19] Business Line Data and Key Metrics Changes - Sales of KedRAB increased to approximately $54 million in 2025, exceeding the contract minimum commitment [10] - GLASSIA contributed total revenue of $35 million, with growth in both ex-U.S. markets and royalty income from Takeda [10] - Revenues from Cytogam declined due to increased usage of antivirals, with ongoing efforts to demonstrate its advantages through a new clinical study [11][12] Market Data and Key Metrics Changes - The company secured a $10 million-$14 million extension of an existing tender from Canadian Blood Services for various products, ensuring ongoing sales in Canada from Q2 2026 to Q1 2028 [17] - The distribution segment is expected to grow through the launch of additional biosimilars in Israel and expansion into the MENA region [9][14] Company Strategy and Development Direction - The company focuses on expanding its commercial product portfolio, including investment in FDA-approved specialty plasma-derived products and biosimilars [9] - Plans to ramp up plasma collection at new centers in Houston and San Antonio, with expected annual revenues of $8 million-$10 million at full capacity [15] - The company aims to secure new business development and M&A transactions to enhance its product portfolio and generate synergies [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to meet supply obligations despite geopolitical challenges in the Middle East [4] - The company affirmed its 2026 annual guidance of $200 million-$205 million in revenues and $50 million-$53 million in adjusted EBITDA, representing 13% and 23% growth, respectively [8] - Management emphasized the importance of Cytogam as additional protection for high-risk organ transplant recipients and the potential for increased usage following clinical studies [25] Other Important Information - A dividend of $0.25 per share, totaling approximately $14.4 million, was declared, reinforcing confidence in business prospects and liquidity for growth investments [6][7] Q&A Session Summary Question: CMV market and Cytogam usage - Management noted no changes in CMV management protocols but acknowledged increased access to antivirals affecting Cytogam usage [23][24] Question: M&A opportunities and dividend implications - Management confirmed that the dividend payment does not indicate a change in M&A opportunities, expressing optimism for securing transactions in 2026 [26] Question: Plasma collection growth margin benefits - Management expects growth margin benefits from proprietary plasma collection to start impacting gross profit in 2027 and beyond [27] Question: Plasma collection center ramp-up - Current ramp-up is at 30%-40%, with full capacity expected by the end of 2027 [31] Question: Timing for new biosimilars - New biosimilars are expected to launch around mid-2026, with sales ramping up based on market demand [32] Question: Dividend payment timing - The entire dividend will be paid out in the second quarter [40]

Verrica Pharmaceuticals (NasdaqGM:VRCA) Q4 2025 Earnings call March 11, 2026 08:30 AM ET Company ParticipantsChris Chapman - Chief Commercial OfficerDavid Zawitz - Chief Operating OfficerJayson Rieger - President and CEOJohn Kirby - Interim Chief Financial OfficerKevin Gardner - Managing DirectorConference Call ParticipantsDennis Ding - AnalystDev Prasad - SVP, Biotech Equity Research AnalystKemp Dolliver - Director of Research and Senior AnalystRaghuram Selvaraju - Managing Director, Senior Healthcare Anal ...

Financial Data and Key Metrics Changes - The company reported a consolidated total revenue increase of 66% in 2025, reaching $245.7 million, up from $148 million in 2024 [13] - Adjusted EBITDA for the full year was approximately $18.6 million, an 83% increase from $10.2 million in the previous year [29] - Net income for the year was $15.1 million, a 153% increase from $6 million in 2024, with diluted EPS improving 133% from $0.24 to $0.56 per share [28][29] Business Line Data and Key Metrics Changes - Revenue from procurement services totaled $197.5 million, up 68% from $117.5 million in 2024, with gross profit margins expanding from 6.7% to 7.7% [13] - Systems integration segment revenue increased 78% year-over-year to $40.3 million, with Q4 revenues rising from $7.9 million to $14.2 million [16] - Facilities management revenue totaled $7.9 million, down 1% from the previous year, but discrete project revenues in Q4 increased 263% to $2.5 million [15] Market Data and Key Metrics Changes - The demand for AI infrastructure is accelerating, with a significant majority of medium and large enterprises piloting or planning to implement AI in production workflows, with adoption rates cited at 70%-80% [7] - The company is positioned to capture market share in AI rack integration, with expectations of continued revenue and EPS growth in fiscal 2026 and beyond [6][9] Company Strategy and Development Direction - The company aims to seize market share in AI rack integration and expand modular data center capabilities, focusing on strategic growth through partnerships and potential acquisitions [9][33] - The long-term agreement with the primary customer was amended to extend the term and update pricing, reflecting the investments made in infrastructure and power capabilities [8][21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the business outlook for 2026, forecasting continued growth in earnings with adjusted EBIT expected in the $20-$22 million range [32] - The company acknowledged supply chain volatility and the dynamic market environment but remains confident in its ability to meet increased demand for AI infrastructure [5][10] Other Important Information - The company ended 2025 with $85.5 million in unrestricted cash, a significant increase from the previous year, and cash flow from operations rose from $15.3 million to over $30 million [29][30] - SG&A expenses increased by 56% to $20.7 million, primarily due to higher headcount and stock compensation [25] Q&A Session Summary Question: Can you give any more color on the amended agreement with your largest customer? - The agreement included adjustments in term length and financial support for infrastructure investments, but minimum order volumes remained unchanged [38][41] Question: How does the rack order volume this quarter compare with internal expectations? - Q4 rack volume nearly exceeded the total for Q1 through Q3, with expectations to double the business in 2026 compared to 2025 [45] Question: What is the outlook for the procurement business given recent government disruptions? - The procurement business is expected to remain strong, with opportunities that can materialize quickly, despite previous disruptions [49][50] Question: How has the memory chip shortage impacted the integration business? - The company is somewhat insulated from the memory chip shortage due to strong supply chain management by its key partner [56] Question: How do the economics change as server racks get bigger and heavier? - The company is prepared for increased complexity and power requirements, with ongoing discussions about potential economic adjustments as rack sizes increase [58]

Verrica Pharmaceuticals (NasdaqGM:VRCA) Q4 2025 Earnings call March 11, 2026 08:30 AM ET Company ParticipantsChris Chapman - Chief Commercial OfficerDavid Zawitz - Chief Operating OfficerJayson Rieger - President and CEOJohn Kirby - Interim Chief Financial OfficerKevin Gardner - Managing DirectorConference Call ParticipantsDev Prasad - SVP, Biotech Equity Research AnalystGeorgia Bank - AnalystKemp Dolliver - Director of Research and Senior AnalystRaghuram Selvaraju - Managing Director, Senior Healthcare Ana ...

Financial Data and Key Metrics Changes - In Q4 2025, the company delivered 780 homes, generating $260 million in revenue, a 9% decrease from the previous year [11] - The home closing gross margin was 19.9%, down from 25.5% in Q4 2024 [11] - Net income for Q4 was $17 million, or $0.39 per diluted share, compared to $30 million in the prior year [12] - For the full year 2025, the company delivered 2,908 homes, a 1% increase over 2024, with revenue of $971 million, essentially flat year-over-year [13][14] - Adjusted net income for Q4 was $12.8 million, down from $22.7 million in the same period last year [13] Business Line Data and Key Metrics Changes - The average sales price for homes was $334,000 in Q4 2025, down from $340,000 in 2024 [14] - Net new orders for the year were 2,726 homes, a 3% increase compared to 2024, with an average order price of $333,000 [15] - The company ended the year with 512 homes in backlog, valued at approximately $173 million [15] Market Data and Key Metrics Changes - The company experienced a 28% increase in active community count, reaching 100 communities compared to 78 at the end of 2024 [15] - Total controlled lots increased by 14% to approximately 22,300 lots, primarily through option contracts [16] Company Strategy and Development Direction - The company aims to grow volume and gain market share through targeted investments and a disciplined approach to home building [8][10] - The focus remains on building affordable homes in markets with strong population growth and job creation [9] - The company maintains a conservative balance sheet and prioritizes land ownership discipline [10] Management's Comments on Operating Environment and Future Outlook - Management noted that the housing market has been in a recessionary environment for about 18 months, driven by affordability pressures and higher mortgage rates [19] - The macroeconomic environment remains uncertain, with mixed signals from recent economic data and geopolitical developments [20] - The company expects closings in Q1 2026 to be between 575 and 625 homes, with average sales prices between $330,000 and $335,000 [21] Other Important Information - The company has seen an uptick in traffic and order activity relative to Q4 levels, although demand remains inconsistent [7] - The company is focused on maintaining pace and aligning sales absorption with production capacity [18] Q&A Session Summary Question: Sales pace and pricing trends in Q1 - Management indicated that sales pace followed traditional seasonal patterns, with an uptick in February and early March [24][26] Question: Trends across major markets - Management noted similarities in market pacing, with new markets expected to perform similarly once models are open [28] Question: Incentives and margin guidance for Q1 - Management explained that they leaned heavily into incentives in Q4, with a focus on maintaining sales pace while monitoring margins [34][35] Question: SG&A expenses and unusual items - Management clarified that SG&A expenses were impacted by new divisions not yet fully operational, leading to higher costs [45][46] Question: Land pricing trends - Management noted that while land costs are expected to increase in 2026, there are signs of a reset in pricing for new deals [56][57] Question: Spec count and inventory strategy - Management stated that specs are running about half of current inventory, with a focus on pre-sold homes to maximize value [65][66] Question: Land acquisition strategy - Management prefers finished lot purchases and is seeing softening opportunities in better locations [70][71]